American Journal of Cardiology
Volume 103, Issue 8 , Pages 1120-1127, 15 April 2009

Race, Gender, and Mortality in Adults ≥65 Years of Age With Incident Heart Failure (from the Cardiovascular Health Study)

  • Susmita Parashar, MD, MPH, MS

      Affiliations

    • Department of Medicine, Emory University School of Medicine, Atlanta, Georgia
    • Corresponding Author InformationCorresponding author: Tel: 404-712-1655; Fax: 404-727-6495
  • ,
  • Ronit Katz, DPhil

      Affiliations

    • Department of Epidemiology, University of Washington, Seattle Epidemiologic Research and Information Center, Seattle, Washington
  • ,
  • Nicholas L. Smith, PhD

      Affiliations

    • Department of Epidemiology, University of Washington, Seattle Epidemiologic Research and Information Center, Seattle, Washington
    • Veterans Affairs Puget Sound Health Care System, Seattle, Washington
  • ,
  • Alice M. Arnold, PhD

      Affiliations

    • Department of Epidemiology, University of Washington, Seattle Epidemiologic Research and Information Center, Seattle, Washington
  • ,
  • Viola Vaccarino, MD, PhD

      Affiliations

    • Department of Medicine, Emory University School of Medicine, Atlanta, Georgia
  • ,
  • Nanette K. Wenger, MD

      Affiliations

    • Department of Medicine, Emory University School of Medicine, Atlanta, Georgia
  • ,
  • John S. Gottdiener, MD

      Affiliations

    • Division of Cardiology, University of Maryland, Baltimore, Maryland

Received 25 August 2008; received in revised form 21 December 2008; accepted 21 December 2008.

In patients with heart failure (HF), mortality is lower in women versus men. However, it is unknown whether the survival advantage in women compared with men is present in both whites and African Americans with HF. The inception cohort consisted of adults ≥65 years with incident HF after enrollment in the CHS, a prospective population-based study of cardiovascular disease. Of 5,888 CHS subjects, 1,264 developed new HF and were followed up for 3 years. Subjects were categorized into 4 race-gender groups, and Cox proportional hazard regression models were used to examine whether 3-year total and cardiovascular mortality differed among the 4 groups after adjusting for sociodemographic factors, co-morbidities, and treatment. A gender-race interaction was also tested for each outcome. In subjects with incident HF, African Americans had more hypertension and diabetes than whites, and white men had more coronary heart disease than other gender-race groups. Receipt of cardiovascular treatments among the 4 groups was similar. Mortality rates after HF were lower in women compared with men (for white women, African-American women, African-American men, and white men, total mortality was 35.5, 33.6, 44.4, and 40.5/100 person-years, and cardiovascular mortality was 18.4, 19.5, 20.2, and 22.7/100 person-years, respectively). After adjusting for covariates, women had a 15% to 20% lower risk of total and cardiovascular mortality compared with men, but there was no significant difference in outcome by race. The gender-race interaction for either outcome was not significant. In conclusion, in older adults with HF, women had significantly better survival than men irrespective of race, suggesting that gender-based survival differences may be more important than race-based differences.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 This work was supported by contracts N01-HC-35129, N01-HC-45133, N01-HC-75150, N01-HC-85079 through N01-HC-85086, N01 HC-15103, N01 HC-55222, and U01 HL080295 from the National Heart, Lung, and Blood Institute, Bethesda, Maryland, with additional contribution from the National Institute of Neurological Disorders and Stroke, Bethesda, Maryland. Dr. Parashar was supported by Scientist Development Award 0630084N from the American Heart Association, Dallas, Texas, and Mentored Clinical Scientist Development Award 1K23RR023171 from the National Center for Research Resources/National Institutes of Health.

PII: S0002-9149(09)00056-3

doi:10.1016/j.amjcard.2008.12.043

American Journal of Cardiology
Volume 103, Issue 8 , Pages 1120-1127, 15 April 2009